ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 238 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $2,504,613 | +170.9% | 154,130 | +208.3% | 0.01% | +400.0% |
Q1 2024 | $924,500 | -88.3% | 50,000 | -80.1% | 0.00% | -94.1% |
Q4 2023 | $7,871,491 | +236.9% | 251,405 | +124.3% | 0.02% | +240.0% |
Q3 2023 | $2,336,185 | +303.9% | 112,101 | +364.2% | 0.01% | +150.0% |
Q2 2023 | $578,416 | -92.7% | 24,151 | -94.2% | 0.00% | -98.3% |
Q1 2023 | $7,890,153 | +257.5% | 419,243 | +202.4% | 0.12% | +195.0% |
Q4 2022 | $2,206,830 | -40.0% | 138,620 | -38.3% | 0.04% | -42.9% |
Q3 2022 | $3,675,000 | +10.7% | 224,629 | -4.6% | 0.07% | -23.1% |
Q2 2022 | $3,319,000 | +487.4% | 235,527 | +909.0% | 0.09% | +506.7% |
Q1 2022 | $565,000 | -62.6% | 23,342 | -64.0% | 0.02% | -68.1% |
Q4 2021 | $1,512,000 | -23.1% | 64,775 | -45.2% | 0.05% | -16.1% |
Q3 2021 | $1,965,000 | +324.4% | 118,276 | +522.5% | 0.06% | +250.0% |
Q2 2021 | $463,000 | -52.8% | 19,000 | -17.1% | 0.02% | -74.6% |
Q4 2019 | $981,000 | +111.9% | 22,930 | +78.1% | 0.06% | +133.3% |
Q3 2019 | $463,000 | -52.4% | 12,873 | -64.6% | 0.03% | -74.8% |
Q2 2019 | $973,000 | – | 36,400 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 647,833 | $26,723,000 | 11.32% |
GREAT POINT PARTNERS LLC | 1,921,563 | $79,264,000 | 7.13% |
Baker Brothers Advisors | 41,904,586 | $1,728,564,000 | 6.91% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 486,000 | $20,048,000 | 6.47% |
Palo Alto Investors LP | 1,832,300 | $75,582,000 | 4.15% |
Birchview Capital, LP | 204,000 | $8,416,000 | 2.81% |
SECTORAL ASSET MANAGEMENT INC | 556,514 | $22,956,000 | 1.97% |
Rock Springs Capital Management LP | 1,573,200 | $64,895,000 | 1.65% |
Riggs Asset Managment Co. Inc. | 17,470 | $2,025,000 | 0.85% |
PFM Health Sciences, LP | 421,087 | $17,370,000 | 0.80% |